RCM
BMY icon

Richardson Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Richardson Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,000
Closed -$103K – 145
2023
Q4 		$103K Buy
+2,000
New +$105K 0.1% 42

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Richardson Capital Management's BMY Position: Q1 2024 in Review

Richardson Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2024, closing a stake of 2,000 shares — an estimated $103K sold.

Richardson Capital Management first reported a position in BMY in Q4 2023 and held it in 1 quarter. The position peaked at $103K in Q4 2023. 2,339 funds tracked by Wall St. Rank hold BMY as of Q1 2024.

  • Richardson Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2024 after selling out during the quarter.
  • Richardson Capital Management sold 2,000 Bristol-Myers Squibb shares in Q1 2024, an estimated $103K.
  • Richardson Capital Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 1 quarter.
  • Richardson Capital Management's Bristol-Myers Squibb position peaked at $103K in Q4 2023.
  • 2,339 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2024.

Based on Richardson Capital Management's 13F filing for Q1 2024, filed 17 Apr 2024.